Connecting insufficient sleep and insomnia with metabolic dysfunction

Duan, Daisy, Kim, Lenise J., Jun, Jonathan C., Polotsky, Vsevolod Y.·2023·Annals of the New York Academy of Sciences
DOI 10.1111/nyas.14926

Cites (213)

Items 201–211 of 211

  1. Effects of chronic sleep deprivation on glucose homeostasis in rats
    Xiaowen Xu, Liang Wang, Yan Zhang, Tianjiao Su, Liying Chen, Yan Zhang, Weifeng Ma, Yuanyuan Xie, Tiantian Wang, Fan Yang et al. · 2016 · Sleep and Biological Rhythms
  2. Gender differences in the associations between insomnia and glycemic control in patients with type 2 diabetes: a cross-sectional study
    Chenzhao Ding, Jihui Zhang, Eric S. H. Lau, Andrea O. Y. Luk, Wing Yee So, Ronald C.W., Kai Chow Choi, Juliana C.N. Chan, Yun Kwok Wing, Alice P.S. Kong · 2019 · SLEEP
  3. Evaluation of thrombolysis by using ultrasonic imaging: an in vitro study
    Jui Fang, Po‐Hsiang Tsui · 2015 · Scientific Reports
  4. Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice
    Geng‐Ruei Chang, Po‐Hsun Hou, Wei‐Cheng Yang, Chao‐Ming Wang, Pei-Shan Fan, Huei-Jyuan Liao, To‐Pang Chen · 2021 · Pharmaceuticals
  5. Risk of Type 2 Diabetes in Patients With Nonapnea Sleep Disorders in Using Different Types of Hypnotics
    Chia‐Ling Lin, Mei Chang Yeh, Tomor Harnod, Cheng‐Li Lin, Chia‐Hung Kao · 2015 · Medicine
  6. Effect of mirtazapine on metabolism and energy substrate partitioning in healthy men
    Johannes M. Hennings, Sarah Heel, Katharina Lechner, Manfred Uhr, Tatjana Dose, Ludwig Schaaf, Florian Holsboer, Susanne Lucae, Stephany Fulda, Stefan M. Kloiber · 2019 · JCI Insight
  7. The Use of Antidepressants, Anxiolytics, and Hypnotics in People with Type 2 Diabetes and Patterns Associated with Use: The Hoorn Diabetes Care System Cohort
    Ruth Mast, Simone P. Rauh, Lenka Groeneveld, Anitra D.M. Koopman, Joline W. J. Beulens, A. P. D. Jansen, Marijke A. Bremmer, Amber A. W. A. van der Heijden, Petra J. M. Elders, J. M. Dekker et al. · 2017 · BioMed Research International
  8. Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients
    Orfeu Marcello Buxton, Milena K. Pavlova, Shawn O'Connor, Wei Wang, John Weyl Winkelman · 2017 · Nature and Science of Sleep
  9. Suvorexant as an orexin antagonist may regulate serum glucose levels in psychiatric patients with insomnia
    Masaru Nakamura, Takahiko Nagamine · 2017 · Psychiatry and Clinical Neurosciences
  10. Sleep and Sleep Loss: An Energy Paradox?
    Jonathan C. Jun, Vsevolod Y. Polotsky · 2012 · SLEEP
  11. QuickStats: Percentage* of Adults Aged ≥18 Years Who Took Medication To Help Fall or Stay Asleep Four or More Times in the Past Week,† by Sex and Age Group — National Health Interview Survey, United States, 2017–2018§
    2019 · MMWR Morbidity and Mortality Weekly Report